Evidence map›Paper›PMID 26198599›Full record

ArticleGenetic epidemiology2015

Contemporary Considerations for Constructing a Genetic Risk Score: An Empirical Approach.

Benjamin A Goldstein, Lingyao Yang, Elias Salfati, Themistoclies L Assimes

Abstract read
In one paragraph

Article in Genetic epidemiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Genomic prediction of coronary heart disease.European heart journal · 2016
    Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Genetic Risk Scores.Current protocols in human genetics · 2019
    Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Benjamin A GoldsteinDepartment of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina, United States of America.
Lingyao YangQuantitative Sciences Unit, Stanford School of Medicine, Palo Alto, California, United States of America.
Elias SalfatiDivision of Cardiovascular Medicine, Stanford School of Medicine, Palo Alto, California, United States of America.
Themistoclies L AssimesDivision of Cardiovascular Medicine, Stanford School of Medicine, Palo Alto, California, United States of America.

Funding

Understanding and predicting cardiac events in HD using real-time EHRsK25DK097279 · NIDDK · STANFORD UNIVERSITY · PI GOLDSTEIN, BENJAMIN ALAN · 2013 to 2017
$797k
Determinants of Insulin Mediated Glucose uptake in South AsiansK23DK088942 · NIDDK · STANFORD UNIVERSITY · PI ASSIMES, THEMISTOCLES LEONARD · 2011 to 2014
$724k
NIDDK NIH HHS K23 DK088942NIDDK NIH HHS K25 DK097279
6 · The paper itself

Abstract

Genetic risk scores are an increasingly popular tool for summarizing the cumulative risk of a set of Single Nucleotide Polymorphisms (SNPs) with disease. Typically only the set of the SNPs that have reached genome-wide significance compose these scores. However recent work suggests that including additional SNPs may aid risk assessment. In this paper, we used the Atherosclerosis Risk in Communities (ARIC) Study cohort to illustrate how one can choose the optimal set of SNPs for a genetic risk score (GRS). In addition to P-value threshold, we also examined linkage disequilibrium, imputation quality, and imputation type. We provide a variety of evaluation metrics. Results suggest that P-value threshold had the greatest impact on GRS quality for the outcome of coronary heart disease, with an optimal threshold around 0.001. However, GRSs are relatively robust to both linkage disequilibrium and imputation quality. We also show that the optimal GRS partially depends on the evaluation metric and consequently the way one intends to use the GRS. Overall the implications highlight both the robustness of GRS and a means to empirically choose the best set of GRSs.

Indexed as

Genome-Wide Association StudyCohort StudiesCoronary Artery DiseaseFemaleGenotypeHumansLinkage DisequilibriumMaleMiddle AgedPolymorphism, Single NucleotideRisk Factorscoronary heart diseaserisk assessmentrisk score

Identifiers

PMID26198599
PMCPMC4543537

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.